Abstract

Marcela C. Smid is from the Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, and the Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, Utah; email: [email protected]. Financial Disclosure Funds were paid to University of Utah for Marcela C. Smid from Alydia Inc for being site PI for a study of the JADA device. Funds were paid to the University of Utah for Marcela C. Smid from Gilead Science Inc for study of hepatitis C treatment in pregnancy. Dr. Smid also reports money was paid to her institution from NIDA and CDC and serving as a consultant for Organon and Rhia Ventures.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.